Related Experiment Videos
Complement C3 deficiency: human, animal, and experimental models
L Singer1, H R Colten, R A Wetsel
1Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110.
Insights
Complement component 3 (C3) deficiency impacts immune responses, pathogen clearance, and immune complex processing. Genetic mutations cause C3 deficiency, studied in humans and animals to understand disease roles.
Area of Science:
- Immunology
- Genetics
- Biochemistry
Background:
- The third complement component (C3) is a key multifunctional glycoprotein in the immune system.
- C3 deficiency is observed across diverse human populations and various animal species.
- Previous studies highlight C3's critical roles in immunity, opsonization, phagocytosis, and immune complex clearance.
Purpose of the Study:
- To review the known roles of C3 in immune function.
- To summarize the genetic basis and observed phenotypes of C3 deficiency.
- To discuss the implications of C3 deficiency in disease pathogenesis and the utility of new animal models.
Main Methods:
- Literature review of studies on C3 deficiency in humans and animals.
- Analysis of molecular genetic causes of C3 deficiency.
- Discussion of findings from C3-deficient models, including newly developed murine models.
Main Results:
- C3 is essential for effective opsonization, phagocytosis of pathogens, and solubilization of immune complexes.
- C3 deficiency arises from various genetic mutations, including splicing defects, deletions, and amino acid substitutions.
- Studies in C3-deficient individuals and animals reveal its crucial role in host defense and immune homeostasis.
Conclusions:
- C3 deficiency profoundly affects the immune system, increasing susceptibility to infections.
- Understanding the molecular basis of C3 deficiency is crucial for diagnosing and potentially treating related disorders.
- The development of C3-deficient murine models offers powerful tools for investigating C3's role in diverse disease processes.
Abstract:
The third complement component (C3) is a multifunctional glycoprotein that interacts with numerous serum proteins, cell surface receptors, and membrane-associated regulatory proteins. Deficiencies of C3 have been reported in several human kindred of different ethnic backgrounds and from different geographic regions. In addition, inherited C3 deficiency has been discovered in certain strains of guinea pigs, dogs, and rabbits, and has been experimentally induced in animals by injections of cobra venom factor. Studies of the C3-deficient humans and animals have demonstrated the important roles performed by C3 in the immune response, opsonization and phagocytosis of pathogens, and immune complex solubilization. Current knowledge of the molecular and cellular basis of complement C3 deficiency indicates that C3 deficiency is caused by numerous molecular genetic mutations that include splicing defects, a partial gene deletion, and a critical amino acid substitution. With the advent of gene ablation technology, C3-deficient murine models can now be established, making it possible to examine the role that C3 plays in the molecular pathogenesis of many different diseases.